Skip to content

Investigating the effect of sucralfate 15% gel in decreasing of bedsore degree I & II

Investigating the effect of sucralfate 15% gel in decreasing of bedsore degree I & II , in bedridden patients of Sari Imam Khomeini hospital.

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT201107053014N5
Enrollment
60
Registered
2012-05-02
Start date
2012-01-21
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bedsore. Decubitus ulcer and pressure area

Interventions

Intervention 1: There are 30 case with bedsore rank 1 or 2 in this study that will receive Sucralfate 15% gel during 7 days. Then the ulcer will observe for size, color and discharge. Intervention 2:
Treatment - Drugs
Placebo
There are 30 case with bedsore rank 1 or 2 in this study that will receive Sucralfate 15% gel during 7 days. Then the ulcer will observe for size, color and discharge.
There are 30 control with bedsore rank 1 or 2 in this study that will receive placebo gel during 7 days. Then the ulcer will observe for size, color and discharge.

Sponsors

Mazandaran University of Medical Sciences, Vice chancellor for research
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Inclusion criteria: All of patients that have bedsore I &II degree; base on American Society of Anesthesiology protocols Exclusion criteria: Adverse reaction to the product; Or the bedsore degree increase to III and IV

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Discharge. Timepoint: 7 days. Method of measurement: drainage.;Ulcer size. Timepoint: 7 days. Method of measurement: ruler.;Ulcer color. Timepoint: 7 days. Method of measurement: Observation.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMotahare Ahmadi

Sari Faculty of Pharmacy

sasanpoorneda@gmail.com; m7_ahmadi@yahoo.com+98 212346378

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026